Sodium phosphate oral solution and preparation method thereof

By adding thickener to the oral solution of sodium phosphate, improving taste and stability, the problem that the existing solution is not suitable for children is solved, and a sodium phosphate oral solution suitable for hypophosphatemia is provided, which improves the solution experience and stability of taking.

CN119055587APending Publication Date: 2024-12-03YIYAOTONG (HEBEI) BIOTECHNOLOGY CO LTD
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411217507.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing oral solution of sodium phosphate salt is not suitable for children, and its phosphorus content is generally high, which is not suitable for the treatment of hypophosphatemia. At the same time, existing dosage forms such as tablets and effervescents are not suitable for children.

Method used

The preparation method includes pre-boiling purified water with preservatives, sodium dihydrogen phosphate and disodium hydrogen phosphate, and then adding sweetened water to the addition of sweetened water. Flavor, flavor and thickener until completely dissolved, finally filtered and filled.

Benefits of technology

It improves the taste and stability of the sodium phosphate oral solution, making it more suitable for children and shows good drug properties in the treatment of hypophosphatemia.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005021978970000031
    Figure BDA0005021978970000031
  • Figure BDA0005021978970000032
    Figure BDA0005021978970000032
  • Figure BDA0005021978970000041
    Figure BDA0005021978970000041
Patent Text Reader

Abstract

The invention belongs to the technical field of pharmaceutical preparations, and provides a sodium phosphate oral solution and a preparation method thereof, and every 1000mL of the sodium phosphate oral solution comprises the following components: 30-35g of sodium dihydrogen phosphate monohydrate, 10-15g of disodium hydrogen phosphate, 0.05-0.15 g of a preservative, 5-35g of a sweetening agent, 0.1-1g of essence, 0.5-1g of a thickening agent and the balance of purified water. The sodium phosphate oral solution also has the advantages that the taste is improved, and the stability of the solution is better.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of pharmaceutical preparations, and particularly relates to a sodium phosphate oral solution and a preparation method thereof. Background Art

[0002] Inorganic phosphorus is an essential mineral nutrient for the human body and an important component of the human body. It participates in the metabolic process in life activities. Therefore, phosphorus intake is an important part of human life activities.

[0003] Hypophosphatemia is a serum inorganic phosphorus concentration lower than 0.8mmol / L (2.5mg / dl), which can occur in people of all ages and genders. Common causes include reduced phosphorus intake or malabsorption, excessive renal phosphorus excretion, and phosphorus transfer into cells. Severe hypophosphatemia can lead to serious clinical consequences.

[0004] Phosphorus supplements are often provided in the form of phosphates, and the most commonly used dosage forms in clinical practice are tablets and effervescent tablets, which are not suitable for children. The currently available sodium phosphate oral solution is used as a laxative, and the phosphorus content is generally high, which is not suitable for the treatment of hypophosphatemia.

[0005] Therefore, there is an urgent need in the art to provide a phosphorus supplement that is more suitable for children to take. Summary of the invention

[0006] The invention provides a sodium phosphate oral solution and a preparation method thereof. By adding a thickener into the prescription, the sodium phosphate oral solution has the characteristics of significantly improving the taste of the sodium phosphate oral solution and increasing the stability of the oral solution.

[0007] On the one hand, the present invention provides a sodium phosphate oral solution, each 1000 mL of sodium phosphate oral solution comprises the following components: 30-35 g of sodium dihydrogen phosphate monohydrate, 10-15 g of disodium hydrogen phosphate, 0.05-0.15 g of a preservative, 5-35 g of a sweetener, 0.1-1 g of a flavor, 0.5-1 g of a thickener, and the balance is purified water.

[0008] In some embodiments, the thickening agent includes xanthan gum.

[0009] It is understandable that adding a thickener to the sodium phosphate oral solution can improve the taste and flavor of the solution. The applicant also unexpectedly discovered that after adding a specific thickener, the stability of the sodium phosphate oral solution is improved.

[0010] In some embodiments, the preservative includes one or more of sodium benzoate and potassium sorbate.

[0011] In some embodiments, the sweetener includes one or more of sucrose, sucralose, and stevioside.

[0012] In some embodiments, the flavor includes one or more of sweet orange flavor, strawberry flavor, and banana flavor.

[0013] In some embodiments, each 1000 mL of sodium phosphate oral solution contains the following components: 32-34 g of sodium dihydrogen phosphate monohydrate, 11-13 g of disodium hydrogen phosphate, 0.08-0.12 g of preservative, 15-30 g of sweetener, 0.5-0.9 g of flavor, 0.7-0.9 g of thickener, and the balance is purified water.

[0014] Preferably, each 1000 mL of sodium phosphate oral solution contains the following components: 33 g of sodium dihydrogen phosphate monohydrate, 11.9 g of disodium hydrogen phosphate, 0.1 g of preservative, 20 g of sweetener, 0.5 g of flavor, 0.8 g of thickener, and the balance is purified water.

[0015] On the other hand, the present invention also provides a method for preparing a sodium phosphate oral solution, comprising the following steps:

[0016] Step 1: Boil an appropriate amount of purified water in advance, cool to 50℃-60℃, add preservatives and stir to dissolve, then slowly add sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate into purified water, stirring continuously until dissolved, then add sweetener and flavor, stirring to dissolve, finally slowly add thickener, stirring continuously until completely dissolved, then add purified water to 1000ml and stir evenly;

[0017] Step 2: After the content of sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate is tested to be qualified, the solution is filtered through a 0.22 μm microporous filter membrane;

[0018] Step 3: Filling and sealing.

[0019] In a third aspect, the present invention also provides a sodium phosphate oral solution and use of the sodium phosphate oral solution prepared by the method of the present invention in preparing a drug for treating hypophosphatemia.

[0020] The sodium phosphate oral solution and preparation method thereof of the present invention have the following advantages:

[0021] 1. The taste of the sodium phosphate oral solution of the present invention is improved;

[0022] 2. The sodium phosphate oral solution of the present invention has better stability. DETAILED DESCRIPTION

[0023] Many specific details are set forth in the following description to facilitate a full understanding of the present invention. However, the present invention can be implemented in many other ways than those described herein, and those skilled in the art can make similar modifications without violating the connotation of the present invention, so the present invention is not limited to the specific implementation disclosed below.

[0024] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention.

[0025] Example 1-6 Preparation of sodium phosphate oral solution

[0026] Table 1 Prescription table of Examples 1-6

[0027]

[0028] Preparation method:

[0029] (1) Weighing: Weigh each component according to the prescribed amount and set aside;

[0030] (2) Liquid preparation: Take 600 ml of purified water and boil it in advance, cool it to 50℃-60℃, add the preservative and stir to dissolve, then slowly add sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate into the purified water, stir continuously until dissolved, then add sweetener and flavor, stir to dissolve, and finally slowly add thickener, stir continuously until completely dissolved. Then add water to 1000 ml, stir evenly, and measure the content;

[0031] (3) Filtration: After the content of sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate is tested to be qualified, the solution is filtered through a 0.22 μm microporous filter membrane;

[0032] (4) Filling: Use an automatic canning machine to can, adjust the liquid filling machine to 10 ml per bottle, extract 10 bottles every 10 minutes to check the average filling volume and filling volume difference, and check the product name, batch number, aluminum seal, etc. Comparative Example 1-5 Preparation of sodium phosphate oral solution

[0033] Table 2 Prescription table of comparative examples 1-5

[0034]

[0035]

[0036] The preparation method is shown in Examples 1-6.

[0037] Example 7 Taste Test

[0038] The sodium phosphate oral solutions prepared in Examples 1-6 and Comparative Examples 1-5 were subjected to a multi-factor investigation and evaluation method: ① Take an appropriate amount of solution and put it in your mouth, use your tongue to feel the taste, and after 10 seconds, spit out the sample and fill in Questionnaire 1 (taste, sweetness, bitterness). ② Rinse your mouth, spit out the residue, and then fill in Questionnaire 2 (overall acceptance, taste, flavor intensity, sweetness, bitterness, taste and texture, aftertaste, and the relationship between flavor and sweetness). ③ After waiting for 5 minutes, finally fill in Questionnaire 3 (aftertaste, aftertaste duration + specific comments).

[0039] Table 3 Taste test evaluation results (specific comments)

[0040] Sample name Taste Example 1 Smooth, slightly sweet, fragrant, good taste Example 2 Smooth, slightly sweet, fragrant, good taste Example 3 Smooth, slightly sweet, fragrant, good taste Example 4 Smooth, slightly sweet, fragrant, good taste Example 5 Smooth, slightly sweet, fragrant, good taste Example 6 Smooth, slightly sweet, fragrant, good taste Comparative Example 1 Smooth, not sweet, fragrant, average taste Comparative Example 2 Smooth, too sweet, fragrant, average taste Comparative Example 3 Astringent, slightly sweet, fragrant, average taste Comparative Example 4 Astringent, slightly sweet, fragrant, average taste Comparative Example 5 Astringent, slightly sweet, fragrant, average taste

[0041] From the taste evaluation results in Table 3, it can be seen that the preferred amount of sweetener is 10-30 g, and adding xanthan gum as a thickener can further enhance the taste of the oral solution.

[0042] Example 8 Influencing Factors Experiment

[0043] The sodium phosphate oral solutions prepared in Examples 4, 5, 6 and Comparative Examples 3-5 were placed under strong light irradiation (4500lx±500) and high temperature (60°C) conditions to investigate the influencing factors, and samples were taken on the 5th and 10th days to detect the quality indicators such as appearance, pH value and content, and compared with the test results on day 0. Low temperature tests were also carried out (first placed in a refrigerator at 2°C to 8°C for 2 days, then accelerated at 40°C for 2 days, and repeated three times).

[0044] Table 4 Experimental results of influencing factors

[0045]

[0046]

[0047]

[0048] From the above test results, it can be seen that after the sodium phosphate oral solutions prepared in Examples 4, 5, and 6 were placed under strong light and high temperature conditions for 10 days, all indicators showed no significant changes compared with those on day 0. The indicators measured in the low temperature test also showed no significant changes compared with those on day 0, and there was no crystallization phenomenon.

[0049] Example 9 Stability Test

[0050] The sodium phosphate oral solutions prepared in Examples 4, 5, 6 and Comparative Examples 3-5 were subjected to accelerated tests at a temperature of 40°C ± 2°C and a humidity of 75% ± 5% for 1 month, 3 months and 6 months respectively.

[0051] Table 5 Stability test results

[0052]

[0053]

[0054] From the above test results, it can be seen that the sodium phosphate oral solution prepared in Examples 4, 5, and 6 meets the requirements for accelerated testing at a temperature of 40°C ± 2°C and a humidity of 75% ± 5% for 1 month, 3 months, and 6 months.

Claims

1. A sodium phosphate oral solution, characterized in that: Each 1000mL of sodium phosphate oral solution contains the following components: 30-35g of sodium dihydrogen phosphate monohydrate, 10-15g of disodium hydrogen phosphate, 0.05-0.15g of preservative, 5-35g of sweetener, 0.1-1g of flavor, 0.5-1g of thickener, and the balance is purified water.

2. The oral solution according to claim 1, characterized in that The thickener includes xanthan gum.

3. The oral solution according to claim 1, characterized in that The preservative includes one or more of sodium formate and potassium sorbate.

4. The oral solution according to claim 1, characterized in that The sweetener includes one or more of sucrose, sucralose, and stevioside.

5. The oral solution according to claim 1, characterized in that The flavor includes one or more of sweet orange flavor, strawberry flavor, and banana flavor.

6. The oral solution according to claim 1, characterized in that Each 1000 mL of sodium phosphate oral solution contains the following components: 32-34 g of sodium dihydrogen phosphate monohydrate, 11-13 g of disodium hydrogen phosphate, 0.08-0.12 g of preservative, 15-30 g of sweetener, 0.5-0.9 g of flavor, 0.7-0.9 g of thickener, and the balance is purified water.

7. The oral solution according to claim 6, characterized in that Each 1000 mL of sodium phosphate oral solution contains the following components: 33 g of sodium dihydrogen phosphate monohydrate, 11.9 g of disodium hydrogen phosphate, 0.1 g of preservative, 20 g of sweetener, 0.5 g of flavor, 0.8 g of thickener, and the balance is purified water.

8. A method for preparing the sodium phosphate oral solution according to claims 1-7, characterized in that: The following steps are involved: Step 1: Boil an appropriate amount of purified water in advance, cool to 50℃-60℃, add preservatives and stir to dissolve, then slowly add sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate into purified water, stirring continuously until dissolved, then add sweetener and flavor, stirring to dissolve, finally slowly add thickener, stirring continuously until completely dissolved, then add purified water to 1000ml and stir evenly; Step 2: After the content of sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate is tested to be qualified, the solution is filtered through a 0.22 μm microporous filter membrane; Step 3: Filling and sealing.

9. Use of the sodium phosphate oral solution according to claims 1 to 7 and the sodium phosphate oral solution prepared by the method according to claim 8 in preparing a drug for treating hypophosphatemia.

Citation Information

Cited By

  • Tendered oral phosphate solution

    BE1033365B1

  • Palatable phosphate oral solution

    WO2026171759A1